Comparison of Liver Health in Psoriatic Arthritis Patients Using Anti-TNF or Anti-IL17 Treatments
N/A
Psoriatic arthritis (PsA) is an inflammatory joint disease that can also af...
Status
Not Yet Recruiting
Location
Bezmialem Vakif University
Start Date
2025-04-10
Trial ID
NCT06918886
Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17
NA
Fiber is the main source of energy for colonic bacteria and its consumption...
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)
PHASE3
The core and extension studies assessed the safety and efficacy of secukinu...
The primary purpose of the study is to help answer the following research q...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.